These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 32948204

  • 1. miRNAs expression signature potentially associated with lymphatic dissemination in locally advanced prostate cancer.
    Pudova EA, Krasnov GS, Nyushko KM, Kobelyatskaya AA, Savvateeva MV, Poloznikov AA, Dolotkazin DR, Klimina KM, Guvatova ZG, Simanovsky SA, Gladysh NS, Tokarev AT, Melnikova NV, Dmitriev AA, Alekseev BY, Kaprin AD, Kiseleva MV, Snezhkina AV, Kudryavtseva AV.
    BMC Med Genomics; 2020 Sep 18; 13(Suppl 8):129. PubMed ID: 32948204
    [Abstract] [Full Text] [Related]

  • 2. Identification of microRNA signature and potential pathway targets in prostate cancer.
    Moustafa AA, Ziada M, Elshaikh A, Datta A, Kim H, Moroz K, Srivastav S, Thomas R, Silberstein JL, Moparty K, Salem FE, El-Habit OH, Abdel-Mageed AB.
    Exp Biol Med (Maywood); 2017 Mar 18; 242(5):536-546. PubMed ID: 27903835
    [Abstract] [Full Text] [Related]

  • 3. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y, Sui J, Shen X, Li C, Yao W, Hong W, Peng H, Pu Y, Yin L, Liang G.
    Oncol Rep; 2017 Jun 18; 37(6):3543-3553. PubMed ID: 28498428
    [Abstract] [Full Text] [Related]

  • 4. Biomarker Potential of Plasma MicroRNA-150-5p in Prostate Cancer.
    Paunescu IA, Bardan R, Marcu A, Nitusca D, Dema A, Negru S, Balacescu O, Balacescu L, Cumpanas A, Sirbu IO, Petrut B, Seclaman E, Marian C.
    Medicina (Kaunas); 2019 Sep 03; 55(9):. PubMed ID: 31484346
    [Abstract] [Full Text] [Related]

  • 5. Identification of miRNA signature in cancer-associated fibroblast to predict recurrent prostate cancer.
    Xu W, Liu S, Ma L, Cheng L, Li Q, Qing L, Yang Y, Dong Z.
    Comput Biol Med; 2024 Sep 03; 180():108989. PubMed ID: 39142223
    [Abstract] [Full Text] [Related]

  • 6. A preliminary study of micro-RNAs as minimally invasive biomarkers for the diagnosis of prostate cancer patients.
    Giglio S, De Nunzio C, Cirombella R, Stoppacciaro A, Faruq O, Volinia S, Baldassarre G, Tubaro A, Ishii H, Croce CM, Vecchione A.
    J Exp Clin Cancer Res; 2021 Feb 23; 40(1):79. PubMed ID: 33622375
    [Abstract] [Full Text] [Related]

  • 7. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
    Li H, Xie S, Liu M, Chen Z, Liu X, Wang L, Li D, Zhou Y.
    Int J Oncol; 2014 Jul 23; 45(1):197-208. PubMed ID: 24805774
    [Abstract] [Full Text] [Related]

  • 8. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC, Nicholson HD, Gold EJ.
    Prostate; 2016 Aug 23; 76(11):951-63. PubMed ID: 27018851
    [Abstract] [Full Text] [Related]

  • 9. miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer.
    Josson S, Gururajan M, Hu P, Shao C, Chu GY, Zhau HE, Liu C, Lao K, Lu CL, Lu YT, Lichterman J, Nandana S, Li Q, Rogatko A, Berel D, Posadas EM, Fazli L, Sareen D, Chung LW.
    Clin Cancer Res; 2014 Sep 01; 20(17):4636-46. PubMed ID: 24963047
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification of miRNA signatures and their therapeutic potentials in prostate cancer.
    Karadag A, Ozen A, Ozkurt M, Can C, Bozgeyik I, Kabadere S, Uyar R.
    Mol Biol Rep; 2021 Jul 01; 48(7):5531-5539. PubMed ID: 34318435
    [Abstract] [Full Text] [Related]

  • 12. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
    Li CY, Liang GY, Yao WZ, Sui J, Shen X, Zhang YQ, Peng H, Hong WW, Ye YC, Zhang ZY, Zhang WH, Yin LH, Pu YP.
    Clin Transl Oncol; 2017 Feb 01; 19(2):162-172. PubMed ID: 27173517
    [Abstract] [Full Text] [Related]

  • 13. Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer.
    Lee IH, Kim G, Kwak SG, Baek DW, Kang BW, Kim HJ, Park SY, Park JS, Choi GS, Hur K, Kim JG.
    Genes (Basel); 2021 Jan 27; 12(2):. PubMed ID: 33513887
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data.
    Rana S, Valbuena GN, Curry E, Bevan CL, Keun HC.
    Br J Cancer; 2022 Feb 27; 126(3):502-513. PubMed ID: 35022525
    [Abstract] [Full Text] [Related]

  • 16. Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer.
    Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H.
    Prostate; 2013 Jun 27; 73(8):827-34. PubMed ID: 23184537
    [Abstract] [Full Text] [Related]

  • 17. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.
    Warnecke-Eberz U, Chon SH, Hölscher AH, Drebber U, Bollschweiler E.
    Tumour Biol; 2015 Jun 27; 36(6):4643-53. PubMed ID: 25631748
    [Abstract] [Full Text] [Related]

  • 18. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
    Ghorbanmehr N, Gharbi S, Korsching E, Tavallaei M, Einollahi B, Mowla SJ.
    Prostate; 2019 Jan 27; 79(1):88-95. PubMed ID: 30194772
    [Abstract] [Full Text] [Related]

  • 19. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
    He Q, Fang Y, Lu F, Pan J, Wang L, Gong W, Fei F, Cui J, Zhong J, Hu R, Liang M, Fang L, Wang H, Yu M, Zhang ZF.
    J Clin Lab Anal; 2019 Nov 27; 33(9):e23003. PubMed ID: 31541491
    [Abstract] [Full Text] [Related]

  • 20. [TCM Combined Western Medicine Treatment of Advanced NSCLC: a Preliminary Study of mIRNA Expression Profiles].
    Li YB, Lin LZ, Guan JS, Chen CM, Zuo Q, Lin BQ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Sep 27; 36(9):1076-1081. PubMed ID: 30645846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.